Tel Aviv Sourasky Medical center
Tel Aviv, 64239, Israel
NCT Number: NCT01264198
The aim of the study is to evaluate the effect of RT on clinical and metabolic parameters in patients with NAFLD.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Interventional
Not applicable
Tel Aviv, 64239, Israel
Background: Non Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent liver disease in developed countries with a prevalence rate of 20-30 % of adults. About 10-25% of these individuals are estimated to meet the current diagnostic criteria for Non Alcoholic Steatohepatitis (NASH) and some may progress to Cirrhosis and liver failure. NAFLD is now recognized as the hepatic manifestation of the metabolic syndrome. Recent data shows that NAFLD might also predict the tendency to develop diabetes mellitus and coronary artery disease. The drug of choice for NAFLD is yet to be found. The recommended treatment of NAFLD includes weight reduction and Physical Activity (PA), but the data of the effect of Resistance Training (RT) PA on NAFLD is scant.
Aim of the study: To evaluate the effect of RT on clinical and metabolic parameters in patients with NAFLD. Study design: Randomized Clinical Trial. Patients will be randomly allocated to 2 arms (intervention and control). The intervention arm will perform RT, whereas control arm will be advised to perform home stretching. Medical examination will be performed at week 0 (baseline) and at week 13 using uniform protocols.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Supervised Resistance Training
Time frame: week 0 and week 13
Tel-Aviv Sourasky Medical Center
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00823277
Body Weight, Cardiovascular Diseases
Holbæk, Denmark
View Trial DetailsNCT02690792
Digestive System Diseases, Fatty Liver
Dallas, Texas, United States
View Trial DetailsNCT07308548
Digestive System Diseases, Fatty Liver
Beijing, Beijing Municipality, China
View Trial DetailsNCT07128797
Digestive System Diseases, Fatty Liver
Beijing, Beijing Municipality, China
View Trial Details